Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Nish Chaturvedi(University of Copenhagen), John Fuller(University of Verona), Ruggero Mangili(Europe for Business), S. Bandinelli(Europe for Business), Guiseppe Penno(Europe for Business), Raoul E. Rottiers(Europe for Business)
Cited by 191
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743